PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 23.70
+0.25 (1.07%)
Sep 30, 2025, 5:31 PM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 781.90 million as of September 30, 2025. Its market cap has decreased by -27.39% in one year.
Market Cap
781.90M
Enterprise Value
814.23M
Revenue
344.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.70
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 781.90M, a decrease of -69.82%. That is a compound annual growth rate of -23.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2025 | 773.65M | -17.41% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
| Apr 29, 2021 | 2.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 219.71B |
| Novartis AG | 191.75B |
| Lonza Group AG | 36.51B |
| Galderma Group AG | 32.36B |
| Alcon | 29.19B |
| Sandoz Group AG | 20.13B |
| Straumann Holding AG | 13.91B |
| Sonova Holding AG | 13.16B |